ICH Q7 vs ICH Q10
API manufacturing rules vs the quality system that governs the whole lifecycle.
What a comparison is not
A comparison is SPEQ’s reading of how two published documents differ. Neither is the right answer, it is not a determination of which applies to you, and neither is summarised in a way that replaces reading it.
ICH Q7 is the good-manufacturing-practice guide for active pharmaceutical ingredients (APIs) — the detailed expectations for how a drug substance is made and controlled. ICH Q10 is the model for a Pharmaceutical Quality System spanning the entire product lifecycle. Q7 is domain-specific GMP; Q10 is the overarching management system that GMP operates inside.
| ASPECT | ICH Q7 | ICH Q10 |
|---|---|---|
| What it governs | Manufacture and control of APIs (drug substance) | The quality system across the whole product lifecycle |
| Altitude | Operational GMP detail for API production | Management-system framework (policy, resources, review, improvement) |
| Lifecycle coverage | API manufacturing stage | Development → transfer → commercial → discontinuation |
| Key elements | Facilities, process controls, validation, materials, deviations for APIs | Process performance & product quality monitoring, CAPA, change management, management review |
| Relationship to ICH Q8/Q9 | Applies GMP; benefits from Q9 risk tools | Integrates Q8 (design), Q9 (risk), Q11 (development) into one system |
| Certification/inspection | Inspected as GMP for API sites | Assessed as the quality system underpinning GMP compliance |
Reach for ICH Q7 when the question is how an API must be manufactured and controlled — the concrete GMP expectations for a drug-substance site.
Reach for ICH Q10 when the question is how the quality system as a whole should be structured and governed across the lifecycle — the framework that makes Q7 (and finished-product GMP) sustainable.
They sit at different altitudes and work together. Q10 is the management system; Q7 is the GMP detail for one part of it (the API). A drug-substance manufacturer runs Q7 GMP inside a Q10 quality system — Q10 gives you the governance (monitoring, CAPA, change management, management review) that keeps Q7 compliance from decaying.
ICH Q7 vs ICH Q10: frequently asked questions
Common questions on how ICH Q7 and ICH Q10 differ and when each applies.
Is ICH Q7 part of ICH Q10?
Not literally, but conceptually Q7 GMP operates inside a Q10 quality system. Q10 is the lifecycle management framework; Q7 is the GMP guidance for manufacturing APIs. A mature API site demonstrates both.
Does ICH Q7 cover finished drug products?
No. Q7 is specific to active pharmaceutical ingredients (drug substance). Finished-product GMP is covered by regional regulations (21 CFR 211, EU GMP Part I) — though Q10 as a quality-system model applies to both API and finished-product operations.
Where do excipients fit?
Neither Q7 nor Q10 governs excipients specifically — Q7 is for APIs. Excipient GMP is addressed by the Joint IPEC-PQG Good Manufacturing Practices Guide, which exists precisely because ICH Q7 covers actives, not excipients.
Which do inspectors cite?
For an API site, inspectors cite Q7-aligned GMP expectations (via regional GMP that references Q7) for operational findings, and look to Q10 elements — CAPA, change management, management review — when assessing whether the quality system is effective.